Literature DB >> 21708195

Infectious dengue-1 virus entry into mosquito C6/36 cells.

Eliana G Acosta1, Viviana Castilla, Elsa B Damonte.   

Abstract

The entry of dengue virus-1 (DENV-1) strain Hawaii into mosquito C6/36 cells was analyzed using a variety of biochemical inhibitors together with electron microscopy. The treatment with ammonium chloride, chlorpromazine, dansylcadaverine and dynasore inhibited virus yields, determined by infectivity titrations, whereas nystatin and methyl-β-cyclodextrin did not have any effect. The effect of the clathrin and dynamin inhibitors on DENV-1 entry was corroborated by detection of internalized virions using immunofluorescence staining. Furthermore, electron micrographs showed the incoming virions attached to electron-dense invaginations of the plasma membrane and within coated vesicles that resembled clathrin-coated pits and vesicles, respectively. The susceptibility to clathrin and dynamin inhibitors of clinical isolates from recent outbreaks was comparable to that shown by the cell culture-adapted reference strain. Similarly, DENV-3 strain H87 and DENV-4 strain 8124 were also inhibited in the presence of ammonium chloride, chlorpromazine and dynasore, allowing conclude that the infectious entry of DENV serotypes to mosquito cells occurs by low pH-dependent clathrin-mediated endocytosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21708195     DOI: 10.1016/j.virusres.2011.06.008

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism.

Authors:  Manjula Kalia; Renu Khasa; Manish Sharma; Minu Nain; Sudhanshu Vrati
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.

Authors:  Brooke Harmon; Benjamin R Schudel; Dianna Maar; Carol Kozina; Tetsuro Ikegami; Chien-Te Kent Tseng; Oscar A Negrete
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 3.  Exploitation of Cytoskeletal Networks during Early Viral Infection.

Authors:  Derek Walsh; Mojgan H Naghavi
Journal:  Trends Microbiol       Date:  2018-07-20       Impact factor: 17.079

4.  Differential requirements in endocytic trafficking for penetration of dengue virus.

Authors:  Eliana G Acosta; Viviana Castilla; Elsa B Damonte
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

5.  Inhibition of dengue virus entry and multiplication into monocytes using RNA interference.

Authors:  Mohammed Abdelfatah Alhoot; Seok Mui Wang; Shamala Devi Sekaran
Journal:  PLoS Negl Trop Dis       Date:  2011-11-29

6.  RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells.

Authors:  Mohammed Abdelfatah Alhoot; Seok Mui Wang; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

7.  ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry.

Authors:  Qian Shu; Nicholas J Lennemann; Saumendra N Sarkar; Yoel Sadovsky; Carolyn B Coyne
Journal:  PLoS Pathog       Date:  2015-09-15       Impact factor: 6.823

8.  Dengue-3 Virus Entry into Vero Cells: Role of Clathrin-Mediated Endocytosis in the Outcome of Infection.

Authors:  Luana E Piccini; Viviana Castilla; Elsa B Damonte
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 9.  Mosquito cell lines: history, isolation, availability and application to assess the threat of arboviral transmission in the United Kingdom.

Authors:  Thomas Walker; Claire L Jeffries; Karen L Mansfield; Nicholas Johnson
Journal:  Parasit Vectors       Date:  2014-08-20       Impact factor: 3.876

10.  A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes.

Authors:  Xiaoping Xiao; Rudian Zhang; Xiaojing Pang; Guodong Liang; Penghua Wang; Gong Cheng
Journal:  PLoS Pathog       Date:  2015-04-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.